Why the study?
No active systemic agents are specifically approved for epithelioid hemangioendothelioma and guidelines on clinical management are lacking, leading to inconsistent treatment adoption and suboptimal outcomes.
This global consensus paper provides evidence-based best practices for the clinical management of epithelioid hemangioendothelioma, addressing the lack of existing guidelines.
No takes yet. Share an insight, caveat, or question.
Establishes first consensus guidelines for EHE management; extends expert framework to guide care and future trials in this rare sarcoma.
Stacchiotti et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: